Many people worry that fat from dairy foods might hurt their heart. This concern grew when scientists found that altering a cow's diet could change the fat in milk. These changes create trans fatty acids, which are often linked to health problems. A new analysis looked closely at this specific type of dairy fat to see if it truly harms people. The team examined data from ten randomized controlled trials and twelve other studies involving many participants. They compared eating dairy foods with these altered fats against eating regular dairy foods. The goal was to see if the altered fat raised the risk of heart disease or type 2 diabetes. They also checked how it affected cholesterol levels in the blood. The results were clear and reassuring for consumers. Eating dairy foods with these specific fats did not increase the risk of heart disease or death from heart disease. It also did not raise the risk of developing type 2 diabetes. The only change seen was a very small drop in good cholesterol, known as HDL-C. This drop was tiny and not considered dangerous. Other measures like total cholesterol and bad cholesterol did not change significantly. The study found no link between eating these dairy foods and negative health effects. This suggests that dairy products from cows with altered diets are safe for most people. The findings help calm fears about a specific type of dairy fat that has been misunderstood. People can continue to eat these foods without worrying about hidden dangers to their heart.
Trans fatty acids from dairy foods show no increased cardiometabolic risk in systematic review and meta-analysisDairy fat with altered cow diets does not raise heart disease risk
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Consider that trans fatty acids from dairy foods may not increase cardiometabolic risk based on current evidence.
This is a systematic review and meta-analysis that synthesized evidence from 10 randomized controlled trials and 12 prospective cohort studies on trans fatty acids from dairy foods. The scope included biomarkers and clinical outcomes for cardiovascular diseases and type 2 diabetes, comparing TFA-enhanced dairy fat to regular dairy foods. The authors found no significant differences in total cholesterol, LDL cholesterol, HDL-C, lipid ratios, triacylglycerols, apolipoproteins, cardiovascular disease incidence, cardiovascular disease mortality, or type 2 diabetes risk. A slight decrease in HDL-C was noted for TFA-enriched vs. regular dairy foods, with an effect size of -0.05 mmol/L and a confidence interval of -0.10 to -0.00. Consumption of TFA (1.3-13.2 g/d) from different dairy types was not linked to adverse effects on cardiometabolic health. Limitations were not reported by the authors. The practice relevance is that dairy-derived trans fats may not pose additional cardiometabolic risk, but the evidence is not definitive.
What this means for you:
Dairy fat from altered cow diets does not raise heart disease or diabetes risk. More on Type 2 Diabetes
GLP-1 receptor agonists and tirzepatide provide cardiovascular benefits across multiple clinical scenarios
Incretin Drugs Show Heart Benefits Across Multiple Conditions
This state-of-the-art review synthesizes evidence regarding incretin analogues, specifically GLP-1 receptor agonists and tirzepatide. The re…
GLP-1 drugs and tirzepatide prove heart benefits in diabetes, obesity, heart failure, and more.
General medical management improves medication adherence and lifestyle outcomes in older adults with type 2 diabetes
New management model improves medication use and health for seniors
This randomized controlled trial of 200 older adults with type 2 diabetes and atherosclerotic cardiovascular disease found that a general me…
A new personalized care plan helps older adults with diabetes and heart disease stay on their medications and improve their daily habits.
Eating later in the biological day is associated with impaired glucose regulation and reduced insulin sensitivity
Eating later in the day is linked to worse blood sugar and heart health markers
This narrative review examines chrononutrition in obesity, type 2 diabetes, hypertension, and cardiovascular disease. Findings indicate that…
A review suggests eating later in the biological day is associated with impaired glucose regulation and reduced insulin sensitivity in peopl…
AI-driven cardiovascular risk prediction in type 2 diabetes shows promise but bias and lack of diversity limit clinical use
New machine learning tools show promise but need better testing for diverse patients with diabetes
This narrative review examines machine learning models for cardiovascular risk prediction in type 2 diabetes. Neural networks showed superio…
Artificial intelligence can predict heart risks for people with type 2 diabetes better than current methods. However, these new tools often …
View Original Abstract ↓
Dairy foods are becoming one of the major dietary sources of trans fatty acids (TFA) as global initiatives to eliminate industrially produced TFA are implemented. This systematic review aimed to assess the cardiometabolic effects of TFA from dairy foods, using data from randomized controlled trials (RCTs) and prospective cohort studies (PCS). We hypothesized that TFA from dairy foods would have no effect on biomarkers for or risk of cardiovascular diseases. Searches for RCTs and PCS were conducted in PubMed and EMBASE using PRISMA guidelines. RCTs compared the impact on blood lipids of regular dairy foods with TFA-enhanced dairy fat/foods produced by altering the cow's diet. Pooled meta-analysis of RCTs using the random effects model was performed for total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol (HDL-C), total cholesterol/HDL-C, low-density lipoprotein cholesterol/HDL-C, triacylglycerols, apolipoprotein A1, and apolipoprotein B as continuous variables. Selected PCS analyzed associations between blood concentrations of trans vaccenic acid or trans palmitoleic acid and risk of cardiovascular diseases or type 2 diabetes. Among 10 RCTs, there were no significant differences in mean difference for any lipid biomarkers except for a slight decrease in HDL-C (mean difference: -0.05 mmol/L; confidence interval: -0.10 to -0.00) for TFA-enriched vs. regular dairy foods. Among 12 PCS, circulating concentrations of trans vaccenic acid or trans palmitoleic acid were not associated with increased risk of cardiovascular diseases incidence, mortality, or type 2 diabetes. Consumption of TFA (1.3-13.2 g/d) from different types of dairy foods was not linked to adverse effects on cardiometabolic health.
AI-OCT reports reduced false-positive DME referral rates from 69.1% to 24.1%
AI technology reduces unnecessary referrals for diabetic macular edema
Related in Diabetes & Endocrinology
Metabolic surgery review outlines framework for T2DM and obesity management
Metabolic Surgery Review Aims to Guide Diabetes Care
This systematic review aims to provide a theoretical framework and practical insights for metabolic surgery in patients with type 2 diabetes…
A new review explores how metabolic surgery fits into type 2 diabetes and obesity treatment, focusing on techniques and outcomes.
Protein acetylation serves as a critical regulatory hub for inflammation and metabolism in atherosclerosis
New Research Identifies Protein Acetylation as Key Link in Atherosclerosis
This systematic review examines protein acetylation as a link between epigenetic regulation and metabolic homeostasis in atherosclerosis. Th…
Scientists have identified protein acetylation as a critical hub for inflammation and metabolism, offering new paths for treating heart dise…
SGLT2 inhibitors and GLP-1 receptor agonists show similar MACE reduction in type 2 diabetes
Trial shows similar heart benefits for two diabetes medications
This systematic review and network meta-analysis compared SGLT2 inhibitors and GLP-1 receptor agonists for major adverse cardiovascular even…
Two common types of diabetes drugs both show significant reductions in major heart events for patients with a history of heart attacks.
SGLT2 inhibitors reduce body fat without significant impacts on skeletal muscle mass in type 2 diabetes
SGLT2 Inhibitors Reduce Fat Mass in Type 2 Diabetes Patients
This network meta-analysis of 5,399 patients evaluated the effects of SGLT2 inhibitors on body composition. The study found that while SGLT2…
New analysis shows SGLT2 inhibitors consistently reduce body fat and weight in adults with type 2 diabetes without significantly reducing mu…
From Other Specialties
Heart rate and GPS metrics are commonly used but lack specific validation for water sports
Monitoring Methods for High Level Surface Water Sports Athletes
This scoping review of 22 papers maps monitoring methods for high-level non-motorized surface water sports athletes. Findings indicate that …
New research maps how elite athletes in sailing and canoeing are monitored, highlighting a need for better data for women and youth competit…
Strategic leadership in sport organizations involves contingent governance, culturally mediated leadership, and configurational performance systems
Strategic leadership in sports varies across cultures, review finds
This systematic review of 38 empirical studies characterizes strategic leadership within international sports competitions. The authors iden…
A review of 38 studies finds strategic leadership in sports depends on culture and governance, not a one-size-fits-all approach.
FDA Approves Dyna-hex 4 (chlorhexidine gluconate) for Healthcare Personnel Handwash
FDA approves Dyna-hex 4 for handwashing and skin cleansing.
The FDA approved Dyna-hex 4 (chlorhexidine gluconate) for healthcare personnel handwash, skin wound cleansing, and general skin cleansing. T…
The FDA approved Dyna-hex 4 (chlorhexidine gluconate) for use as a handwash and skin cleanser in healthcare settings. It helps reduce bacter…
Chlorinated pool air exposure is linked to mucosal irritation and asthma-like symptoms in swimmers
Chlorinated pool air may cause asthma like symptoms in swimmers
This mini review synthesizes evidence regarding the impact of chlorinated pool air on competitive swimmers and workers. The authors conclude…
Swimming in chlorinated pools can lead to lung irritation and inflammation, posing a risk for athletes with sensitive airways.